# TBX21

## Overview
TBX21 is a gene that encodes the T-box transcription factor 21, commonly referred to as T-bet, which is a member of the T-box family of transcription factors. T-bet is characterized by its T-box domain, a conserved DNA-binding region that plays a pivotal role in regulating gene expression. As a transcription factor, T-bet is integral to the immune system, particularly in the differentiation and function of T helper 1 (Th1) cells, where it promotes the production of interferon-gamma (IFNγ), a key cytokine in immune responses against intracellular pathogens (Pritchard2019The). T-bet is expressed in various immune cells, including T cells, natural killer (NK) cells, and B cells, and is involved in modulating immune responses and inflammatory processes (Stone2019Tbet). The gene's expression and function are influenced by various signaling pathways and interactions with other proteins and nucleic acids, highlighting its role in both normal immune function and disease states, such as asthma, cancer, and autoimmune disorders (Zhao2018TBX21; Akahoshi2005Functional).

## Structure
The TBX21 gene encodes the T-bet protein, a member of the T-box family of transcription factors. The protein is characterized by a conserved DNA-binding domain known as the T-box domain, which spans approximately 180-200 amino acids and is crucial for sequence-specific DNA binding (Wilson2002TheTboxfamily; Papaioannou2014The). This domain forms a seven-stranded beta-barrel structure, allowing the protein to interact with DNA either as a monomer or dimer (Nagel2021Establishment).

T-bet is involved in epigenetic regulation, with specific domains within its T-box domain recruiting methyltransferase activity to target promoters, thereby establishing a permissive chromatin state (Papaioannou2014The). The protein can function as a transcriptional activator or repressor, with its regulatory activity requiring sequences in the carboxy-terminal portion of the protein (Wilson2002TheTboxfamily).

Post-translational modifications, such as phosphorylation, may influence the function of T-bet, although specific modifications are not detailed in the provided context. The presence of splice variants could potentially alter the structure and function of the protein, but specific isoforms are not mentioned in the context. Overall, T-bet plays a significant role in immune response regulation through its structural and functional properties.

## Function
The TBX21 gene encodes the T-bet transcription factor, which plays a critical role in the immune system by regulating the differentiation and function of T helper 1 (Th1) cells. T-bet is essential for the production of interferon-gamma (IFNγ), a cytokine crucial for immune responses against intracellular pathogens. It is involved in the differentiation of naive T cells into Th1 cells, which are vital for cellular immunity, and inhibits alternative T cell fates such as Th2 and Th17 cell development (Pritchard2019The).

T-bet is expressed in various immune cells, including CD4+ and CD8+ T cells, natural killer (NK) cells, and B cells. In T cells, T-bet is initially induced upon T cell receptor activation and further regulated by cytokines like IFNγ and IL-12 through the STAT1 and STAT4 pathways (Pritchard2019The). In B cells, T-bet is crucial for the differentiation of antibody-secreting cells (ASCs) and modulates inflammatory responses by repressing IFNγ-induced inflammatory gene programs (Stone2019Tbet).

T-bet's activity is primarily nuclear, where it binds to DNA to modulate gene expression, influencing immune cell differentiation and function. It also plays a role in coordinating T cell trafficking and interactions with dendritic cells, which are essential for T cell priming and immune response regulation (Pritchard2019The).

## Clinical Significance
Mutations and alterations in the TBX21 gene, which encodes the T-bet transcription factor, have been implicated in various diseases. A functional promoter polymorphism, À1993T fi C, in the TBX21 gene is associated with an increased risk of aspirin-induced asthma (AIA). This polymorphism enhances the transcriptional activity of TBX21, potentially contributing to asthma pathogenesis by affecting the Th1/Th2 balance and cytokine production (Akahoshi2005Functional).

In lung adenocarcinoma (LUAD), TBX21 plays a role in maintaining cancer stemness through its interaction with the IL-4 pathway. Alterations in TBX21 expression can impact cancer prognosis, with overexpression linked to increased IL-4 levels and cancer stem cell markers, suggesting its significance in cancer progression (Zhao2018TBX21).

TBX21 expression is also associated with late-onset Alzheimer's disease (LOAD), where elevated levels in peripheral blood leukocytes are linked to specific SNP genotypes, indicating a potential protective role in healthy individuals (Fatemi2023TBX21).

In systemic sclerosis (SSc), TBX21 polymorphisms, such as rs11650354, are associated with increased disease risk, particularly in white populations. These genetic variations may influence the Th1/Th2 cytokine balance, contributing to SSc pathogenesis (Gourh2009Polymorphisms).

## Interactions
TBX21, also known as T-bet, is a transcription factor that plays a crucial role in regulating immune responses. It is involved in various interactions with proteins and nucleic acids that influence its function. TBX21 is known to bind to the promoter region of the IL-4 gene, enhancing its expression and promoting cancer stemness in lung adenocarcinoma (Zhao2018TBX21). This interaction is part of the TBX21-IL-4 signaling pathway, which is critical for maintaining cancer stemness in lung adenocarcinoma cells (Zhao2018TBX21).

In the context of colorectal cancer, TBX21 interacts with genes such as MX1 and SP140, which are enriched in pathways related to the regulation of TP53 activity. These interactions suggest a role for TBX21 in modulating CD8+ T cell function, potentially impacting immune response and patient outcomes (Shen2022TBX21). TBX21 is also involved in the regulation of interferon-γ production and PD-1 expression, which are crucial for T cell exhaustion and immune response (Shen2022TBX21).

These interactions highlight TBX21's role in immune regulation and its potential impact on various diseases, including cancer and autoimmune disorders.


## References


[1. (Pritchard2019The) Gretchen Harms Pritchard, Ross M. Kedl, and Christopher A. Hunter. The evolving role of t-bet in resistance to infection. Nature Reviews Immunology, 19(6):398–410, March 2019. URL: http://dx.doi.org/10.1038/s41577-019-0145-4, doi:10.1038/s41577-019-0145-4. This article has 58 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41577-019-0145-4)

[2. (Wilson2002TheTboxfamily) Val Wilson and Frank L Conlon. The t-box family. Genome Biology, 3(6):reviews3008.1, 2002. URL: http://dx.doi.org/10.1186/gb-2002-3-6-reviews3008, doi:10.1186/gb-2002-3-6-reviews3008. This article has 244 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2002-3-6-reviews3008)

[3. (Akahoshi2005Functional) Mitsuteru Akahoshi, Kazuhiko Obara, Tomomitsu Hirota, Akira Matsuda, Koichi Hasegawa, Naomi Takahashi, Makiko Shimizu, Kazuko Nakashima, Lei Cheng, Satoru Doi, Hiroshi Fujiwara, Akihiko Miyatake, Kimie Fujita, Noritaka Higashi, Masami Taniguchi, Tadao Enomoto, Xiao-Quan Mao, Hitoshi Nakashima, Chaker N. Adra, Yusuke Nakamura, Mayumi Tamari, and Taro Shirakawa. Functional promoter polymorphism in the tbx21 gene associated with aspirin-induced asthma. Human Genetics, 117(1):16–26, April 2005. URL: http://dx.doi.org/10.1007/s00439-005-1285-0, doi:10.1007/s00439-005-1285-0. This article has 69 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-005-1285-0)

[4. (Stone2019Tbet) Sara L. Stone, Jessica N. Peel, Christopher D. Scharer, Christopher A. Risley, Danielle A. Chisolm, Michael D. Schultz, Bingfei Yu, André Ballesteros-Tato, Wojciech Wojciechowski, Betty Mousseau, Ravi S. Misra, Adedayo Hanidu, Huiping Jiang, Zhenhao Qi, Jeremy M. Boss, Troy D. Randall, Scott R. Brodeur, Ananda W. Goldrath, Amy S. Weinmann, Alexander F. Rosenberg, and Frances E. Lund. T-bet transcription factor promotes antibody-secreting cell differentiation by limiting the inflammatory effects of ifn-γ on b cells. Immunity, 50(5):1172-1187.e7, May 2019. URL: http://dx.doi.org/10.1016/j.immuni.2019.04.004, doi:10.1016/j.immuni.2019.04.004. This article has 96 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2019.04.004)

[5. (Papaioannou2014The) Virginia E. Papaioannou. The t-box gene family: emerging roles in development, stem cells and cancer. Development, 141(20):3819–3833, October 2014. URL: http://dx.doi.org/10.1242/dev.104471, doi:10.1242/dev.104471. This article has 230 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.104471)

[6. (Fatemi2023TBX21) S. R. Fatemi Langroudi, M. Zeinaly, and F. Ajamian. Tbx21, the master regulator of the type 1 immune response, overexpresses in the leukocytes of peripheral blood in patients with late-onset alzheimer’s disease. Immunity &amp; Ageing, November 2023. URL: http://dx.doi.org/10.1186/s12979-023-00385-1, doi:10.1186/s12979-023-00385-1. This article has 1 citations.](https://doi.org/10.1186/s12979-023-00385-1)

[7. (Shen2022TBX21) Yuanyuan Shen, Yulia I. Nussbaum, Yariswamy Manjunath, Justin J. Hummel, Matthew A. Ciorba, Wesley C. Warren, Jussuf T. Kaifi, Christos Papageorgiou, Rene Cortese, Chi-Ren Shyu, and Jonathan B. Mitchem. Tbx21 methylation as a potential regulator of immune suppression in cms1 subtype colorectal cancer. Cancers, 14(19):4594, September 2022. URL: http://dx.doi.org/10.3390/cancers14194594, doi:10.3390/cancers14194594. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers14194594)

[8. (Nagel2021Establishment) Stefan Nagel and Corinna Meyer. Establishment of the tbx-code reveals aberrantly activated t-box gene tbx3 in hodgkin lymphoma. PLOS ONE, 16(11):e0259674, November 2021. URL: http://dx.doi.org/10.1371/journal.pone.0259674, doi:10.1371/journal.pone.0259674. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0259674)

[9. (Zhao2018TBX21) Shuangtao Zhao, Wenzhi Shen, Jiangyong Yu, and Luhua Wang. Tbx21 predicts prognosis of patients and drives cancer stem cell maintenance via the tbx21–il-4 pathway in lung adenocarcinoma. Stem Cell Research &amp; Therapy, April 2018. URL: http://dx.doi.org/10.1186/s13287-018-0820-6, doi:10.1186/s13287-018-0820-6. This article has 19 citations.](https://doi.org/10.1186/s13287-018-0820-6)

[10. (Gourh2009Polymorphisms) Pravitt Gourh, Sandeep K. Agarwal, Dipal Divecha, Shervin Assassi, Gene Paz, Rajpreet K. Arora‐Singh, John D. Reveille, Sanjay Shete, Maureen D. Mayes, Frank C. Arnett, and Filemon K. Tan. Polymorphisms in tbx21 and stat4 increase the risk of systemic sclerosis: evidence of possible gene–gene interaction and alterations in th1/th2 cytokines. Arthritis &amp; Rheumatism, 60(12):3794–3806, November 2009. URL: http://dx.doi.org/10.1002/art.24958, doi:10.1002/art.24958. This article has 87 citations.](https://doi.org/10.1002/art.24958)